Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04160312 · ClinicalTrials.gov registry record · NA
Mitopure™ (Proprietary Urolithin A) Bioavailability in Healthy Adults
A NA study, sponsored by Amazentis.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT04160312 is a NA study that has completed, run by Amazentis. The registered enrollment target is 100 participants.
The verdict
NCT04160312, a NA study, has completed, sponsored by Amazentis.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This is a single-center, two-period, crossover, randomized, open labelled study enrolling 100 healthy subjects to evaluate the Urolithin A producer status and to compare bioavailabilty of direct dietary supplementation with Mitopure™ (proprietary Urolithin A) to dietary exposure with pomegranate juice
Interventions
- DIETARY_SUPPLEMENT Pomegranate Juice
- DIETARY_SUPPLEMENT Mitopure™ (Proprietary Urolithin A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-11-08 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04160312
The ClinicalTrials.gov registry entry for NCT04160312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amazentis, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pomegranate Juice is the first listed.
NCT04160312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04160312 about?
NCT04160312 is a clinical study titled "Mitopure™ (Proprietary Urolithin A) Bioavailability in Healthy Adults". This is a single-center, two-period, crossover, randomized, open labelled study enrolling 100 healthy subjects to evaluate the Urolithin A producer status and to compare bioavailabilty of direct dietary supplementation with Mitopure™ (proprietary Urolithin A) to dietary exposure with pomegranate jui...
What is the current status of trial NCT04160312?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-11-08. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT04160312?
The interventions under investigation include: Pomegranate Juice (DIETARY_SUPPLEMENT), Mitopure™ (Proprietary Urolithin A) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04160312?
This trial is sponsored by Amazentis, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.